Berger Mark Stanley Insider Trades

Insider Trading History

Track insider trading activity for Berger Mark Stanley. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $15.1k 21,692 shares
Last Trade
Feb 27, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.3k 7,168 shares
$2.00
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $20.1k 28,860 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.3k 28,500 shares
$2.01
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $12.5k 17,971 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.04k 4,500 shares
$0.23
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $15.6k 22,471 shares
Last Trade
Feb 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$240 585 shares
$0.41
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $16k 23,056 shares
Last Trade
Dec 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.7k 18,250 shares
$1.08
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $3.34k 4,806 shares
Last Trade
Feb 18, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.8k 1,319 shares
$4.40
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $170k 245,000 shares
Last Trade
Feb 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 245,000 shares
$1.71
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $68.6k 98,750 shares
Last Trade
Feb 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$217k 98,750 shares
$2.20
$0.70
Genprex
Genprex GNPX
Chief Medical Officer
Holding Value $382k 550,000 shares
Last Trade
Sep 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 550,000 shares
$2.85
$0.70
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $74.6k 67,164 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$408k 67,164 shares
$6.07
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $51.8k 46,667 shares
Last Trade
Aug 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 46,667 shares
$9.55
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $444k 400,000 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 400,000 shares
$6.96
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $25k 22,500 shares
Last Trade
Mar 05, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$65.1k 3,500 shares
$18.60
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $278k 250,000 shares
Last Trade
Jul 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.87M 250,000 shares
$23.49
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $21.1k 19,000 shares
Last Trade
Mar 06, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$365k 28,000 shares
$13.05
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $5.55k 5,000 shares
Last Trade
Jun 15, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$173k 5,000 shares
$34.50
$1.11
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 17, 2017 Sale
$10.1M 325,000 shares
$31.20
$1.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up